APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Viable Bone Matrix

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medical Viable Bone Matrix Industry Growth and Trends Forecast to 2032

4 July 2026105 pages

Choose your research edition.

Industry ResearchMedical Viable Bone Matrix Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Viable Bone Matrix Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Medical Viable Bone Matrix Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Viable Bone Matrix Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Viable Bone Matrix Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medical Viable Bone Matrix market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Viable Bone Matrix is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Viable Bone Matrix is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Viable Bone Matrix is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Viable Bone Matrix include Arthrex, Aziyo, DePuy Synthes, DJO, Medline Industries, LP, Spinal Elements, Inc., Surgalign Spine Technologies, Inc., Surgalign Spine Technologies, Inc. and SurGenTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Viable Bone Matrix market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Viable Bone Matrix market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Viable Bone Matrix market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Viable Bone Matrix.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medical Viable Bone Matrix market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Viable Bone Matrix Market by Company

Arthrex

Aziyo

DePuy Synthes

DJO

Medline Industries, LP

Spinal Elements, Inc.

Surgalign Spine Technologies, Inc.

Surgalign Spine Technologies, Inc.

SurGenTec

SurGenTec

VIVEX Biologics

XTANT MEDICAL

Zimmer Biomet

Stryker

Medical Viable Bone Matrix Segment by Type

Demineralized Bone Fibrous Matrix

Moldable Viable Bone Matrix

Medical Viable Bone Matrix Segment by Application

Hospital

Orthopedic Surgery Center

Others

Medical Viable Bone Matrix Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Viable Bone Matrix market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Viable Bone Matrix and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Viable Bone Matrix.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Viable Bone Matrix manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medical Viable Bone Matrix in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Demineralized Bone Fibrous Matrix Table 2. Major Company of Moldable Viable Bone Matrix Table 3. Global Medical Viable Bone Matrix Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 5. Global Medical Viable Bone Matrix Sales Market Share in Volume by Type (2021-2026) Table 6. Global Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 7. Global Medical Viable Bone Matrix Sales Market Share in Value by Type (2021-2026) Table 8. Global Medical Viable Bone Matrix Price by Type (2021-2026) & (USD/g) Table 9. Global Medical Viable Bone Matrix Sales by Type (2027-2032) & (kg) Table 10. Global Medical Viable Bone Matrix Sales Market Share in Volume by Type (2027-2032) Table 11. Global Medical Viable Bone Matrix Sales by Type (2027-2032) & (US$ Million) Table 12. Global Medical Viable Bone Matrix Sales Market Share in Value by Type (2027-2032) Table 13. Global Medical Viable Bone Matrix Price by Type (2027-2032) & (USD/g) Table 14. North America Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 15. North America Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 17. Europe Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 21. Latin America Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Medical Viable Bone Matrix Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Medical Viable Bone Matrix Sales by Type (2021-2026) & (US$ Million) Table 24. Medical Viable Bone Matrix Industry Trends Table 25. Medical Viable Bone Matrix Industry Drivers Table 26. Medical Viable Bone Matrix Industry Opportunities and Challenges Table 27. Medical Viable Bone Matrix Industry Restraints Table 28. Global Medical Viable Bone Matrix Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Medical Viable Bone Matrix Revenue Market Share by Company (2021-2026) Table 30. Global Medical Viable Bone Matrix Sales by Company (2021-2026) & (kg) Table 31. Global Medical Viable Bone Matrix Sales Share by Company (2021-2026) Table 32. Global Medical Viable Bone Matrix Market Price by Company (2021-2026) & (USD/g) Table 33. Global Medical Viable Bone Matrix Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Medical Viable Bone Matrix Major Company Production Sites and Headquarters Table 35. Global Medical Viable Bone Matrix Company, Product Type & Application Table 36. Global Medical Viable Bone Matrix Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Medical Viable Bone Matrix by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Medical Viable Bone Matrix Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Medical Viable Bone Matrix Sales by Region (2021-2026) & (kg) Table 41. Global Medical Viable Bone Matrix Sales Market Share in Volume by Region (2021-2026) Table 42. Global Medical Viable Bone Matrix Sales by Region (2021-2026) & (US$ Million) Table 43. Global Medical Viable Bone Matrix Sales Market Share in Value by Region (2021-2026) Table 44. Global Medical Viable Bone Matrix Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Medical Viable Bone Matrix Sales by Region (2027-2032) & (kg) Table 46. Global Medical Viable Bone Matrix Sales Market Share in Volume by Region (2027-2032) Table 47. Global Medical Viable Bone Matrix Sales by Region (2027-2032) & (US$ Million) Table 48. Global Medical Viable Bone Matrix Sales Market Share in Value by Region (2027-2032) Table 49. Global Medical Viable Bone Matrix Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Medical Viable Bone Matrix Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 52. Global Medical Viable Bone Matrix Sales Market Share in Volume by Application (2021-2026) Table 53. Global Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 54. Global Medical Viable Bone Matrix Sales Market Share in Value by Application (2021-2026) Table 55. Global Medical Viable Bone Matrix Price by Application (2021-2026) & (USD/g) Table 56. Global Medical Viable Bone Matrix Sales by Application (2027-2032) & (kg) Table 57. Global Medical Viable Bone Matrix Sales Market Share in Volume by Application (2027-2032) Table 58. Global Medical Viable Bone Matrix Sales by Application (2027-2032) & (US$ Million) Table 59. Global Medical Viable Bone Matrix Sales Market Share in Value by Application (2027-2032) Table 60. Global Medical Viable Bone Matrix Price by Application (2027-2032) & (USD/g) Table 61. North America Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 62. North America Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 64. Europe Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 68. Latin America Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Medical Viable Bone Matrix Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Medical Viable Bone Matrix Sales by Application (2021-2026) & (US$ Million) Table 71. Arthrex Company Information Table 72. Arthrex Business Overview Table 73. Arthrex Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Arthrex Medical Viable Bone Matrix Product Portfolio Table 75. Arthrex Recent Development Table 76. Aziyo Company Information Table 77. Aziyo Business Overview Table 78. Aziyo Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. Aziyo Medical Viable Bone Matrix Product Portfolio Table 80. Aziyo Recent Development Table 81. DePuy Synthes Company Information Table 82. DePuy Synthes Business Overview Table 83. DePuy Synthes Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. DePuy Synthes Medical Viable Bone Matrix Product Portfolio Table 85. DePuy Synthes Recent Development Table 86. DJO Company Information Table 87. DJO Business Overview Table 88. DJO Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. DJO Medical Viable Bone Matrix Product Portfolio Table 90. DJO Recent Development Table 91. Medline Industries, LP Company Information Table 92. Medline Industries, LP Business Overview Table 93. Medline Industries, LP Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. Medline Industries, LP Medical Viable Bone Matrix Product Portfolio Table 95. Medline Industries, LP Recent Development Table 96. Spinal Elements, Inc. Company Information Table 97. Spinal Elements, Inc. Business Overview Table 98. Spinal Elements, Inc. Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. Spinal Elements, Inc. Medical Viable Bone Matrix Product Portfolio Table 100. Spinal Elements, Inc. Recent Development Table 101. Surgalign Spine Technologies, Inc. Company Information Table 102. Surgalign Spine Technologies, Inc. Business Overview Table 103. Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Product Portfolio Table 105. Surgalign Spine Technologies, Inc. Recent Development Table 106. Surgalign Spine Technologies, Inc. Company Information Table 107. Surgalign Spine Technologies, Inc. Business Overview Table 108. Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Product Portfolio Table 110. Surgalign Spine Technologies, Inc. Recent Development Table 111. SurGenTec Company Information Table 112. SurGenTec Business Overview Table 113. SurGenTec Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 114. SurGenTec Medical Viable Bone Matrix Product Portfolio Table 115. SurGenTec Recent Development Table 116. SurGenTec Company Information Table 117. SurGenTec Business Overview Table 118. SurGenTec Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 119. SurGenTec Medical Viable Bone Matrix Product Portfolio Table 120. SurGenTec Recent Development Table 121. VIVEX Biologics Company Information Table 122. VIVEX Biologics Business Overview Table 123. VIVEX Biologics Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 124. VIVEX Biologics Medical Viable Bone Matrix Product Portfolio Table 125. VIVEX Biologics Recent Development Table 126. XTANT MEDICAL Company Information Table 127. XTANT MEDICAL Business Overview Table 128. XTANT MEDICAL Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 129. XTANT MEDICAL Medical Viable Bone Matrix Product Portfolio Table 130. XTANT MEDICAL Recent Development Table 131. Zimmer Biomet Company Information Table 132. Zimmer Biomet Business Overview Table 133. Zimmer Biomet Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 134. Zimmer Biomet Medical Viable Bone Matrix Product Portfolio Table 135. Zimmer Biomet Recent Development Table 136. Stryker Company Information Table 137. Stryker Business Overview Table 138. Stryker Medical Viable Bone Matrix Sales (kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 139. Stryker Medical Viable Bone Matrix Product Portfolio Table 140. Stryker Recent Development Table 141. North America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 142. North America Medical Viable Bone Matrix Sales by Country (2021-2026) & (kg) Table 143. North America Medical Viable Bone Matrix Sales Market Share by Country (2021-2026) Table 144. North America Medical Viable Bone Matrix Sales Forecast by Country (2027-2032) & (kg) Table 145. North America Medical Viable Bone Matrix Sales Market Share Forecast by Country (2027-2032) Table 146. North America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Medical Viable Bone Matrix Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Medical Viable Bone Matrix Market Share by Country (2021-2026) Table 149. North America Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Medical Viable Bone Matrix Market Share Forecast by Country (2027-2032) Table 151. Europe Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 152. Europe Medical Viable Bone Matrix Sales by Country (2021-2026) & (kg) Table 153. Europe Medical Viable Bone Matrix Sales Market Share by Country (2021-2026) Table 154. Europe Medical Viable Bone Matrix Sales Forecast by Country (2027-2032) & (kg) Table 155. Europe Medical Viable Bone Matrix Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Medical Viable Bone Matrix Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Medical Viable Bone Matrix Market Share by Country (2021-2026) Table 159. Europe Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Medical Viable Bone Matrix Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Medical Viable Bone Matrix Sales by Country (2021-2026) & (kg) Table 163. Asia-Pacific Medical Viable Bone Matrix Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Medical Viable Bone Matrix Sales Forecast by Country (2027-2032) & (kg) Table 165. Asia-Pacific Medical Viable Bone Matrix Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Medical Viable Bone Matrix Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Medical Viable Bone Matrix Market Share by Country (2021-2026) Table 169. Asia-Pacific Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Medical Viable Bone Matrix Market Share Forecast by Country (2027-2032) Table 171. Latin America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 172. Latin America Medical Viable Bone Matrix Sales by Country (2021-2026) & (kg) Table 173. Latin America Medical Viable Bone Matrix Sales Market Share by Country (2021-2026) Table 174. Latin America Medical Viable Bone Matrix Sales Forecast by Country (2027-2032) & (kg) Table 175. Latin America Medical Viable Bone Matrix Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Medical Viable Bone Matrix Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Medical Viable Bone Matrix Market Share by Country (2021-2026) Table 179. Latin America Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Medical Viable Bone Matrix Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Medical Viable Bone Matrix Sales by Country (2021-2026) & (kg) Table 183. Middle East and Africa Medical Viable Bone Matrix Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Medical Viable Bone Matrix Sales Forecast by Country (2027-2032) & (kg) Table 185. Middle East and Africa Medical Viable Bone Matrix Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Medical Viable Bone Matrix Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Medical Viable Bone Matrix Market Share by Country (2021-2026) Table 189. Middle East and Africa Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Medical Viable Bone Matrix Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Medical Viable Bone Matrix Distributors List Table 194. Medical Viable Bone Matrix Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Medical Viable Bone Matrix Image Figure 2. Global Medical Viable Bone Matrix Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Viable Bone Matrix Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Viable Bone Matrix Sales (2021-2032) & (kg) Figure 5. Demineralized Bone Fibrous Matrix Image Figure 6. Global Demineralized Bone Fibrous Matrix Sales YoY Growth (2021-2032) & (kg) Figure 7. Moldable Viable Bone Matrix Image Figure 8. Global Moldable Viable Bone Matrix Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Medical Viable Bone Matrix Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Medical Viable Bone Matrix Market Share by Type 2025 VS 2032 Figure 11. North America Medical Viable Bone Matrix Sales Market Share in Volume by Type in 2025 Figure 12. North America Medical Viable Bone Matrix Sales Market Share in Value by Type in 2025 Figure 13. Europe Medical Viable Bone Matrix Sales Market Share in Volume by Type in 2025 Figure 14. Europe Medical Viable Bone Matrix Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Medical Viable Bone Matrix Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Medical Viable Bone Matrix Sales Market Share in Value by Type in 2025 Figure 17. Latin America Medical Viable Bone Matrix Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Medical Viable Bone Matrix Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Medical Viable Bone Matrix Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Medical Viable Bone Matrix Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Medical Viable Bone Matrix Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (kg) Figure 25. Orthopedic Surgery Center Image Figure 26. Global Orthopedic Surgery Center Sales YoY Growth (2021-2032) & (kg) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (kg) Figure 29. Global Medical Viable Bone Matrix Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Medical Viable Bone Matrix Market Share by Application 2025 VS 2032 Figure 31. North America Medical Viable Bone Matrix Sales Market Share in Volume by Application in 2025 Figure 32. North America Medical Viable Bone Matrix Sales Market Share in Value by Application in 2025 Figure 33. Europe Medical Viable Bone Matrix Sales Market Share in Volume by Application in 2025 Figure 34. Europe Medical Viable Bone Matrix Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Medical Viable Bone Matrix Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Medical Viable Bone Matrix Sales Market Share in Value by Application in 2025 Figure 37. Latin America Medical Viable Bone Matrix Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Medical Viable Bone Matrix Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Medical Viable Bone Matrix Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Medical Viable Bone Matrix Sales Market Share in Value by Application in 2025 Figure 41. North America Medical Viable Bone Matrix Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 42. North America Medical Viable Bone Matrix Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Medical Viable Bone Matrix Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Medical Viable Bone Matrix Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Medical Viable Bone Matrix Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. Europe Medical Viable Bone Matrix Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Medical Viable Bone Matrix Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Medical Viable Bone Matrix Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Medical Viable Bone Matrix Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Asia-Pacific Medical Viable Bone Matrix Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Medical Viable Bone Matrix Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Medical Viable Bone Matrix Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medical Viable Bone Matrix Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Latin America Medical Viable Bone Matrix Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Medical Viable Bone Matrix Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Medical Viable Bone Matrix Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Medical Viable Bone Matrix Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Middle East and Africa Medical Viable Bone Matrix Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Medical Viable Bone Matrix Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Medical Viable Bone Matrix Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Medical Viable Bone Matrix Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Medical Viable Bone Matrix Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Demineralized Bone Fibrous Matrix
  • Moldable Viable Bone Matrix
Applications
  • Hospital
  • Orthopedic Surgery Center
  • Others
Companies covered
  • Arthrex
  • Aziyo
  • DePuy Synthes
  • DJO
  • Medline Industries, LP
  • Spinal Elements, Inc.
  • Surgalign Spine Technologies, Inc.
  • Surgalign Spine Technologies, Inc.
  • SurGenTec
  • SurGenTec
  • VIVEX Biologics
  • XTANT MEDICAL
  • Zimmer Biomet
  • Stryker

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Viable Bone Matrix Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medical Viable Bone Matrix Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medical Viable Bone Matrix Market by Type
  6. 1.3.1 Demineralized Bone Fibrous Matrix
  7. 1.3.2 Moldable Viable Bone Matrix
  8. 1.4 Global Medical Viable Bone Matrix Market Size by Type
  9. 1.4.1 Global Medical Viable Bone Matrix Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Medical Viable Bone Matrix Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Medical Viable Bone Matrix Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Medical Viable Bone Matrix Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Medical Viable Bone Matrix Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Medical Viable Bone Matrix Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Medical Viable Bone Matrix Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Medical Viable Bone Matrix Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medical Viable Bone Matrix Industry Trends
  2. 2.2 Medical Viable Bone Matrix Industry Drivers
  3. 2.3 Medical Viable Bone Matrix Industry Opportunities and Challenges
  4. 2.4 Medical Viable Bone Matrix Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medical Viable Bone Matrix Revenue (2021-2026)
  2. 3.2 Global Top Players by Medical Viable Bone Matrix Sales (2021-2026)
  3. 3.3 Global Top Players by Medical Viable Bone Matrix Price (2021-2026)
  4. 3.4 Global Medical Viable Bone Matrix Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Viable Bone Matrix Major Company Production Sites & Headquarters
  6. 3.6 Global Medical Viable Bone Matrix Company, Product Type & Application
  7. 3.7 Global Medical Viable Bone Matrix Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Viable Bone Matrix Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Viable Bone Matrix Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Viable Bone Matrix Tier 1, Tier 2, and Tier 3
4 Medical Viable Bone Matrix Regional Status and Outlook
  1. 4.1 Global Medical Viable Bone Matrix Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medical Viable Bone Matrix Historic Market Size by Region
  3. 4.2.1 Global Medical Viable Bone Matrix Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medical Viable Bone Matrix Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medical Viable Bone Matrix Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medical Viable Bone Matrix Forecasted Market Size by Region
  7. 4.3.1 Global Medical Viable Bone Matrix Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medical Viable Bone Matrix Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medical Viable Bone Matrix Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Viable Bone Matrix by Application
  1. 5.1 Medical Viable Bone Matrix Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Orthopedic Surgery Center
  4. 5.1.3 Others
  5. 5.2 Global Medical Viable Bone Matrix Market Size by Application
  6. 5.2.1 Global Medical Viable Bone Matrix Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Medical Viable Bone Matrix Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Medical Viable Bone Matrix Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Medical Viable Bone Matrix Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Medical Viable Bone Matrix Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Medical Viable Bone Matrix Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Medical Viable Bone Matrix Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Medical Viable Bone Matrix Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Arthrex
  2. 6.1.1 Arthrex Company Information
  3. 6.1.2 Arthrex Business Overview
  4. 6.1.3 Arthrex Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Arthrex Medical Viable Bone Matrix Product Portfolio
  6. 6.1.5 Arthrex Recent Developments
  7. 6.2 Aziyo
  8. 6.2.1 Aziyo Company Information
  9. 6.2.2 Aziyo Business Overview
  10. 6.2.3 Aziyo Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aziyo Medical Viable Bone Matrix Product Portfolio
  12. 6.2.5 Aziyo Recent Developments
  13. 6.3 DePuy Synthes
  14. 6.3.1 DePuy Synthes Company Information
  15. 6.3.2 DePuy Synthes Business Overview
  16. 6.3.3 DePuy Synthes Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 DePuy Synthes Medical Viable Bone Matrix Product Portfolio
  18. 6.3.5 DePuy Synthes Recent Developments
  19. 6.4 DJO
  20. 6.4.1 DJO Company Information
  21. 6.4.2 DJO Business Overview
  22. 6.4.3 DJO Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DJO Medical Viable Bone Matrix Product Portfolio
  24. 6.4.5 DJO Recent Developments
  25. 6.5 Medline Industries, LP
  26. 6.5.1 Medline Industries, LP Company Information
  27. 6.5.2 Medline Industries, LP Business Overview
  28. 6.5.3 Medline Industries, LP Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Medline Industries, LP Medical Viable Bone Matrix Product Portfolio
  30. 6.5.5 Medline Industries, LP Recent Developments
  31. 6.6 Spinal Elements, Inc.
  32. 6.6.1 Spinal Elements, Inc. Company Information
  33. 6.6.2 Spinal Elements, Inc. Business Overview
  34. 6.6.3 Spinal Elements, Inc. Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Spinal Elements, Inc. Medical Viable Bone Matrix Product Portfolio
  36. 6.6.5 Spinal Elements, Inc. Recent Developments
  37. 6.7 Surgalign Spine Technologies, Inc.
  38. 6.7.1 Surgalign Spine Technologies, Inc. Company Information
  39. 6.7.2 Surgalign Spine Technologies, Inc. Business Overview
  40. 6.7.3 Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Product Portfolio
  42. 6.7.5 Surgalign Spine Technologies, Inc. Recent Developments
  43. 6.8 Surgalign Spine Technologies, Inc.
  44. 6.8.1 Surgalign Spine Technologies, Inc. Company Information
  45. 6.8.2 Surgalign Spine Technologies, Inc. Business Overview
  46. 6.8.3 Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Surgalign Spine Technologies, Inc. Medical Viable Bone Matrix Product Portfolio
  48. 6.8.5 Surgalign Spine Technologies, Inc. Recent Developments
  49. 6.9 SurGenTec
  50. 6.9.1 SurGenTec Company Information
  51. 6.9.2 SurGenTec Business Overview
  52. 6.9.3 SurGenTec Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SurGenTec Medical Viable Bone Matrix Product Portfolio
  54. 6.9.5 SurGenTec Recent Developments
  55. 6.10 SurGenTec
  56. 6.10.1 SurGenTec Company Information
  57. 6.10.2 SurGenTec Business Overview
  58. 6.10.3 SurGenTec Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SurGenTec Medical Viable Bone Matrix Product Portfolio
  60. 6.10.5 SurGenTec Recent Developments
  61. 6.11 VIVEX Biologics
  62. 6.11.1 VIVEX Biologics Company Information
  63. 6.11.2 VIVEX Biologics Business Overview
  64. 6.11.3 VIVEX Biologics Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 VIVEX Biologics Medical Viable Bone Matrix Product Portfolio
  66. 6.11.5 VIVEX Biologics Recent Developments
  67. 6.12 XTANT MEDICAL
  68. 6.12.1 XTANT MEDICAL Company Information
  69. 6.12.2 XTANT MEDICAL Business Overview
  70. 6.12.3 XTANT MEDICAL Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 XTANT MEDICAL Medical Viable Bone Matrix Product Portfolio
  72. 6.12.5 XTANT MEDICAL Recent Developments
  73. 6.13 Zimmer Biomet
  74. 6.13.1 Zimmer Biomet Company Information
  75. 6.13.2 Zimmer Biomet Business Overview
  76. 6.13.3 Zimmer Biomet Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zimmer Biomet Medical Viable Bone Matrix Product Portfolio
  78. 6.13.5 Zimmer Biomet Recent Developments
  79. 6.14 Stryker
  80. 6.14.1 Stryker Company Information
  81. 6.14.2 Stryker Business Overview
  82. 6.14.3 Stryker Medical Viable Bone Matrix Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Stryker Medical Viable Bone Matrix Product Portfolio
  84. 6.14.5 Stryker Recent Developments
7 North America by Country
  1. 7.1 North America Medical Viable Bone Matrix Sales by Country
  2. 7.1.1 North America Medical Viable Bone Matrix Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medical Viable Bone Matrix Sales by Country (2021-2026)
  4. 7.1.3 North America Medical Viable Bone Matrix Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medical Viable Bone Matrix Market Size by Country
  6. 7.2.1 North America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medical Viable Bone Matrix Market Size by Country (2021-2026)
  8. 7.2.3 North America Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medical Viable Bone Matrix Sales by Country
  2. 8.1.1 Europe Medical Viable Bone Matrix Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medical Viable Bone Matrix Sales by Country (2021-2026)
  4. 8.1.3 Europe Medical Viable Bone Matrix Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medical Viable Bone Matrix Market Size by Country
  6. 8.2.1 Europe Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medical Viable Bone Matrix Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medical Viable Bone Matrix Sales by Country
  2. 9.1.1 Asia-Pacific Medical Viable Bone Matrix Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medical Viable Bone Matrix Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medical Viable Bone Matrix Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medical Viable Bone Matrix Market Size by Country
  6. 9.2.1 Asia-Pacific Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medical Viable Bone Matrix Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medical Viable Bone Matrix Sales by Country
  2. 10.1.1 South America Medical Viable Bone Matrix Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medical Viable Bone Matrix Sales by Country (2021-2026)
  4. 10.1.3 South America Medical Viable Bone Matrix Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medical Viable Bone Matrix Market Size by Country
  6. 10.2.1 South America Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medical Viable Bone Matrix Market Size by Country (2021-2026)
  8. 10.2.3 South America Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medical Viable Bone Matrix Sales by Country
  2. 11.1.1 Middle East and Africa Medical Viable Bone Matrix Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medical Viable Bone Matrix Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medical Viable Bone Matrix Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medical Viable Bone Matrix Market Size by Country
  6. 11.2.1 Middle East and Africa Medical Viable Bone Matrix Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medical Viable Bone Matrix Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medical Viable Bone Matrix Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medical Viable Bone Matrix Value Chain Analysis
  2. 12.1.1 Medical Viable Bone Matrix Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medical Viable Bone Matrix Production Mode & Process
  7. 12.2 Medical Viable Bone Matrix Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medical Viable Bone Matrix Distributors
  10. 12.2.3 Medical Viable Bone Matrix Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst